Skip to main content

Table 1 Physiological data

From: Impact of hyperglycemia on cystathionine-γ-lyase expression during resuscitated murine septic shock

 

Normo. Sham (n = 6)

Normo. CLP (n = 6)

Hyper. Sham (n = 6)

Hyper. CLP (n = 5)

p value

NoA (ng/(g · h))

0 (0; 0)

20 (10; 30)

0 (0; 0)

30 (20; 100)b, c

0.001

HR (beats/min)

310 (310; 315)

481 (397; 503)b

420 (380; 450)a

479 (459; 492)c

0.002

MAP (mmHg)

60 (58; 66)

60 (56; 62)

69 (68; 73)

58 (57; 58)

0.026

Portal ven. flow (ml/min)

4.3 (3.4; 4.7)

6.1 (4.5; 11.0)

4.8 (3.4; 5.8)

6.2 (5.2; 7.3)

0.066

Liver μ-vasc. flow (AU)

122 (109; 127)

111 (93; 176)

132 (120; 148)

133 (105; 147)

0.767

Liver μ-vasc. O2 sat. (%)

61 (58; 63)

61 (58; 64)

64 (60; 66)

65 (60; 66)

0.481

BE (mmol/l)

−7.5 (−10.8; −5.1)

−12.9 (−14.4; −10.9)

−8.2 (−11.0; −7.6)

−13.1 (−13.9; −12.8)

0.067

Lactate (mmol/l)

1.1 (0.9; 1.4)

2.1 (1.8; 2.3)

2.1 (1.7; 2.5)

3.5 (3.4; 3.6)a, b, c

0.002

VCO2 (μl/(g · min))

20.5 (20.2; 20.6)

25.0 (23.2; 26.6)

30.4 (29.0; 33.1)a

26.4 (23.4; 38.9)

0.031

pH

7.45 (7.38; 7.47)

7.28 (7.23; 7.39)

7.35 (7.30; 7.37)

7.25 (7.16; 7.31)

0.112

  1. All data is presented as median (interquartile range). Kruskal-Wallis analysis of variance on ranks with post hoc Dunn’s test for multiple comparisons
  2. Normo normoglycemia, Hyper hyperglycemia, NoA norepinephrine infusion rate, HR heart rate, MAP mean arterial pressure, μ-vasc. microvascular, BE base excess, VCO 2 CO2 production
  3. aSignificant compared to the respective normoglycemic group
  4. bSignificant to respective sham group
  5. cSignificant to normoglycemic sham group